Date published: 2026-2-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

DGCR6 Activators

DiGeorge syndrome critical region gene 6 (DGCR6) is a gene located within a segment of chromosome 22 that has been widely studied for its association with several developmental processes. The DGCR6 gene encodes a protein that is thought to play a crucial role in embryonic development, especially in the neural crest cells, which give rise to a diverse range of tissues and organs in the body. The proper expression of DGCR6 is critical for the normal development of these cells and the structures they form. Research has shown that DGCR6 is involved in the modulation of multiple developmental pathways, and its expression levels can be influenced by a complex network of genetic and environmental factors. Understanding the regulation of DGCR6 is therefore of significant interest in the field of developmental biology.

Within the cellular environment, there are specific chemical compounds that may serve as activators to induce the expression of DGCR6. These activators could include substances that engage with cellular signaling pathways or modify the epigenetic landscape surrounding the DGCR6 gene. For instance, compounds that act as inhibitors of DNA methyltransferases, such as 5-Azacytidine, could lead to the hypomethylation of the DGCR6 gene promoter, resulting in increased transcriptional activity. Similarly, histone deacetylase inhibitors like Trichostatin A or Sodium Butyrate could promote a more open chromatin configuration, potentially enhancing the transcription of DGCR6. Other molecules, including retinoic acid and its derivatives, may bind to their respective nuclear receptors and initiate transcriptional cascades that upregulate DGCR6 expression. Furthermore, signaling molecules such as Forskolin, which increases intracellular cAMP, could activate protein kinase A and catalyze a reaction cascade that culminates in the promotion of DGCR6 gene transcription. These examples illustrate the diverse array of molecular interactions that can contribute to the regulation of gene expression, offering a glimpse into the intricacies of cellular function and gene regulation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic Acid serves as a ligand for retinoic acid receptors which, upon activation, can upregulate gene transcription in a manner that could enhance DGCR6 expression levels during developmental processes.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

Cholecalciferol, when converted to its active form calcitriol, binds to vitamin D receptors, which may stimulate the transcription of genes such as DGCR6 linked to immune response and cellular growth.

β-Estradiol

50-28-2sc-204431
sc-204431A
500 mg
5 g
$63.00
$182.00
8
(1)

β-Estradiol binds estrogen receptors, initiating a cascade that can lead to the transcriptional activation of genes, potentially increasing expression levels of DGCR6 as part of developmental and reproductive processes.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin elevates intracellular cAMP levels, which activates PKA and can lead to the enhancement of transcriptional activity, possibly including the upregulation of DGCR6 gene expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A inhibits histone deacetylases, promoting a more open chromatin state and facilitating the transcriptional activation of a variety of genes, which may include the DGCR6 gene.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine, by inhibiting DNA methyltransferase, could lead to the reactivation of silenced genes, potentially stimulating the expression of DGCR6 through epigenetic reprogramming.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium inhibits GSK-3, a negative regulator of the Wnt signaling pathway, which might lead to the transcriptional activation of Wnt target genes, potentially stimulating DGCR6 expression.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Epigallocatechin Gallate may exert its effect through the inhibition of DNA methyltransferases, possibly leading to the hypomethylation and subsequent upregulation of certain genes, including possibly DGCR6.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Dexamethasone binds to glucocorticoid receptors, which may stimulate the transcription of anti-inflammatory genes and could upregulate the expression of DGCR6 as part of the stress response.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium Butyrate's inhibitory action on histone deacetylases results in increased histone acetylation and can stimulate gene expression by promoting a transcriptionally active chromatin state, which could include the gene DGCR6.